Related Experiment Videos
Mild cognitive impairment: a treatment at last?
Hervé Allain1, Danièle Bentué-Ferrer, Yvette Akwa
1Laboratory of Clinical and Experimental Pharmacology, Centre Mémoire Ressource Recherche de Bretagne, Faculty of Medicine University of Rennes1, France. Herve.Allain@univ-rennes1.fr
The Lancet. Neurology
|October 19, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An intelligent garment for long COVID-19 real-time monitoring.
Computers in biology and medicine·2024
The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions.
International journal of molecular sciences·2023
The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system.
The Biochemical journal·2022
Nestorone® , a 19nor-progesterone derivative boosts remyelination in an animal model of demyelination.
CNS neuroscience & therapeutics·2020
Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential.
International journal of molecular sciences·2020
Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.
The Lancet. Neurology·2026
Advances in chronic subdural haematoma management: beyond the burr hole.
The Lancet. Neurology·2026
A Qualitative Co-Production Study of a Solutions-Focused Approach to Understanding the Barriers and Facilitators to Engagement of Male Suicidal Prisoners in Psychological Therapy for Suicide Prevention.
Health expectations : an international journal of public participation in health care and health policy·2026
Technology Matters: Integrating digital treatments for children and young people with anxiety disorders into routine care.
Child and adolescent mental health·2026